Topics

TOPICS

ANEMIA

Impact on HRQOL Varies in Young Patients With Iron-Deficiency Anemia

Voxelotor Shows Efficacy in Children Aged 2 to 4 Years With SCD

BLEEDING DISORDERS

Recombinant Factor FVIII Fc Fusion Protein Linked to Rapid Tolerization in Severe Hemophilia A With Inhibitors

Fitusiran Prophylaxis Linked to Improved Bleeding Rates for Severe Hemophilia A or B Without Inhibitors

GENERAL HEMATOLOGY

ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type

CIRS-G Reveals Accelerated Aging, Early Death in Childhood Cancer Survivors

LEUKEMIA

Inotuzumab Ozogamicin, Blinatumomab May Be Superior to Chemotherapy in Some Elderly Patients With B-Cell ALL

MRD Assessment Improves Risk-Based Treatment in Patients With Pediatric ALL

LYMPHOMA

Gut Microbial Dysbiosis May Play Role in R-CHOP Response in DLBCL

Pirtobrutinib Produces Durable Responses in Relapsed/Refractory MCL

MYELODYSPLASTIC SYNDROMES

Imetelstat May Benefit Patients With Lower Risk MDS

Substantial Proportion of Patients With MDS or AML Not Considered for HCT

MYELOMA

Survey Identifies Worry as a Core Symptom During Multiple Myeloma Treatment

Eligibility Criteria May Influence Disparity in Multiple Myeloma Trial Enrollment

SIDE EFFECT MANAGEMENT

Disruption to Gut Microbiome Predictive of Acute GVHD Severity, Outcomes

ONS Releases Guidelines on the Management of Cancer Treatment–Related Hot Flashes

THALASSEMIAS

Mindfulness-Based Stress Reduction Counseling Shows Benefits for Patients With Thalassemia

Luspatercept Maintains Patient Health-Related Quality of Life in Beta-Thalassemia

THROMBOTIC DISORDERS

2015 to 2019 Saw Increase in ED Use of CTPA for Suspected Pulmonary Embolism

Pulmonary Embolism Symptoms Affected by Disease Severity, Sex, Age, BMI

Next post in Leukemia

A clinician uses a flow cytometer

MRD Assessment Improves Risk-Based Treatment in Patients With Pediatric ALL